DTIL

Precision Biosciences Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth 4/10
  • Value 0/10
Precision Biosciences sales and earnings growth
DTIL Growth
Neutral
  • Revenue Y/Y -62.64%
  • EPS Y/Y 17.05%
  • FCF Y/Y 0.08%
Precision Biosciences gross and profit margin trends
DTIL Profitability
Low
  • Gross margin 100.00%
  • EPS margin -96.70%
  • ROIC 5Y -294.49%
Precision Biosciences net debt vs free cash flow
DTIL Risk
Great
  • Debt / Equity 0.4
  • Debt / FCF 0.0
  • Interest coverage -30.6

Precision Biosciences stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks